Global AI in Medical Diagnostics Market 2021
![](/report_cover/11753/global-ai-in-medical-diagnostics-market-2021_en.gif)
The use of artificial intelligence (AI) is growing rapidly in the medical field, especially in diagnostics and management of treatment. AI in medical diagnosis helps with medical decision making, management, automation, admin, and workflows. According to StrategyHelix, the global ai in medical diagnostics market is expected to increase by US$ 1,817 million during 2021-2027, expanding at a CAGR of 21.6% during the forecast period.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for ai in medical diagnostics. The global ai in medical diagnostics market is segmented on the basis of component, application, end user, and region. Based on component, the global ai in medical diagnostics market is categorized into hardware, software, services. The software segment held the largest share of the global ai in medical diagnostics market in 2020 and is anticipated to hold its share during the forecast period. On the basis of application, the global ai in medical diagnostics market has been segmented into cardiology, neurology, oncology, orthopedics, others. By end user, the global ai in medical diagnostics market has been segmented into hospitals & clinics, diagnostic centers. Geographically, the global ai in medical diagnostics market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).
The global ai in medical diagnostics market is highly competitive. The leading players in the ai in medical diagnostics market include Canon Medical Systems Corporation, DeepMind Technologies Limited, F. Hoffmann-La Roche AG, FUJIFILM Corporation, GE Healthcare, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medtronic plc, Microsoft Corporation, Nvidia Corporation, Siemens Healthineers AG, Xilinx Inc.
Report Scope
Component: hardware, software, services
Application: cardiology, neurology, oncology, orthopedics, others
End user: hospitals & clinics, diagnostic centers
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global ai in medical diagnostics market
Pinpoint growth sectors and trends for investment
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for ai in medical diagnostics. The global ai in medical diagnostics market is segmented on the basis of component, application, end user, and region. Based on component, the global ai in medical diagnostics market is categorized into hardware, software, services. The software segment held the largest share of the global ai in medical diagnostics market in 2020 and is anticipated to hold its share during the forecast period. On the basis of application, the global ai in medical diagnostics market has been segmented into cardiology, neurology, oncology, orthopedics, others. By end user, the global ai in medical diagnostics market has been segmented into hospitals & clinics, diagnostic centers. Geographically, the global ai in medical diagnostics market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).
The global ai in medical diagnostics market is highly competitive. The leading players in the ai in medical diagnostics market include Canon Medical Systems Corporation, DeepMind Technologies Limited, F. Hoffmann-La Roche AG, FUJIFILM Corporation, GE Healthcare, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medtronic plc, Microsoft Corporation, Nvidia Corporation, Siemens Healthineers AG, Xilinx Inc.
Report Scope
Component: hardware, software, services
Application: cardiology, neurology, oncology, orthopedics, others
End user: hospitals & clinics, diagnostic centers
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global ai in medical diagnostics market
Pinpoint growth sectors and trends for investment
PART 1. INTRODUCTION
Scope of the study
Study period
Geographical scope
Research methodology
PART 2. AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
PART 3. MARKET BREAKDOWN BY COMPONENT
Hardware
Software
Services
PART 4. MARKET BREAKDOWN BY APPLICATION
Cardiology
Neurology
Oncology
Orthopedics
Others
PART 5. MARKET BREAKDOWN BY END USER
Hospitals & clinics
Diagnostic centers
PART 6. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 7. KEY COMPANIES
Canon Medical Systems Corporation
DeepMind Technologies Limited
F. Hoffmann-La Roche AG
FUJIFILM Corporation
GE Healthcare
Intel Corporation
International Business Machines Corporation
Koninklijke Philips N.V.
Medtronic plc
Microsoft Corporation
Nvidia Corporation
Siemens Healthineers AG
Xilinx, Inc.
About StrategyHelix
Disclaimer
Scope of the study
Study period
Geographical scope
Research methodology
PART 2. AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
PART 3. MARKET BREAKDOWN BY COMPONENT
Hardware
Software
Services
PART 4. MARKET BREAKDOWN BY APPLICATION
Cardiology
Neurology
Oncology
Orthopedics
Others
PART 5. MARKET BREAKDOWN BY END USER
Hospitals & clinics
Diagnostic centers
PART 6. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 7. KEY COMPANIES
Canon Medical Systems Corporation
DeepMind Technologies Limited
F. Hoffmann-La Roche AG
FUJIFILM Corporation
GE Healthcare
Intel Corporation
International Business Machines Corporation
Koninklijke Philips N.V.
Medtronic plc
Microsoft Corporation
Nvidia Corporation
Siemens Healthineers AG
Xilinx, Inc.
About StrategyHelix
Disclaimer